NCT03826043View on ClinicalTrials.gov

THrombo-Embolic Event in Onco-hematology

NACompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

September 9, 2022

Study Completion Date

September 9, 2022

Conditions
NeoplasmsThrombosisCoagulation Disorder
Interventions
DIAGNOSTIC_TEST

Blood sample analysis

Thrombophilia, blood count and coagulation count

Trial Locations (1)

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT03826043 - THrombo-Embolic Event in Onco-hematology | Biotech Hunter | Biotech Hunter